(19)

(11)

EP 4 823 575 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24904852.1 (22) Date of filing: 12.12.2024

(51) International Patent Classification (IPC):  A61K 31/4462(2006.01) A61P 25/02(2006.01) A61K 31/381(2006.01) A61P 1/16(2006.01) A61P 25/28(2006.01) (52) Cooperative Patent Classification (CPC): A61P 25/02; A61P 25/28; A61P 1/16; A61K 31/4535; A61K 31/445; A61K 45/06   C-Sets: A61K 31/4535, A61K 2300/00; A61K 31/445, A61K 2300/00; (86) International application number: PCT/US2024/059710 (87) International publication number: WO 2025/128784 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 12.12.2023 US 202363609187 P (71) Applicant: Sen-Jam Pharmaceutical Inc. Huntington, NY 11743 (US)	(72) Inventors: IVERSEN, Jacqueline NY 11743 (US) DAHL, Thomas, A. Guilford, CT 06437 (US) (74) Representative: Grund, Martin et al Grund Intellectual Property Group Patentanwälte und Solicitor PartG mbB Steinsdorfstraße 2 80538 München 80538 München (DE)